Randomized nine months clinical comparison of implantation of Taxol eluting (Taxus Express) and Sirolimus eluting (Cypher Select) stents in non-selected patients with coronary artery disease.
Design: * Randomized open multicentre trial. Patients: * 1800 patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation. Inclusion criteria: * Patients with coronary artery disease scheduled for percutaneous coronary intervention with stent implantation. * Signed informed consent. Exclusion criteria: * Participation in other stent studies. Randomization: * Implantation of Taxus Express og Cypher Select stents. Primary end-point: * Combined end-point of cardiac death, new revascularization (PCI or CABG) or myocardial infarction after nine months. Secondary end-points: * Total death after nine months * Cardiac death after nine months * Myocardial infarction after nine months * Index vessel myocardial infarction after nine months * Target lesion revascularization * Target vessel revascularization * Stent thrombosis after nine months End-point evaluation: * End-points will be adjudicated by an independent end-point committee
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
2,095
percutaneous intervention with implantation of drug eluting coronary stent
MACE (cardiac death, myocardial infarction, target vessel revascularisation, target lesion revascularisation, TVF)
Time frame: during 9 months
Total death
Time frame: after 9 months, 2 and 3 years
Cardiac death
Time frame: after 9 months, 2 and 3 years
Myocardial infarction
Time frame: after 9 months, 2 and 3 years
Target vessel revascularisation, target lesion revascularisation, TVF
Time frame: after 9 months, 2 and 3 years
Stent thrombosis
Time frame: after 9 months, 2 and 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.